It eliminates both non-<i>MYCN</i>-amplified (SH-SY5Y and SK-N-SH) and <i>MYCN</i>-amplified (SMS-KCNR) NB cells that exhibit PMA-inducible CCL2 expression but not <i>MYCN</i>-amplified NB cells (IMR-32 and NB-1) that exhibit CCL2 repression, and is offset by reciprocal NB cell-induced Fas-mediated Jurkat cell apoptosis. Here, MYCN is linked to neuroblastoma.